tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market

Eton Pharmaceuticals (ETON) Financial Statements

403 Followers

Eton Pharmaceuticals Financial Overview

Eton Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.033; its P/E ratio is 103.55; Eton Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 7.97M$ 7.03M$ 12.00M$ 5.30M$ 8.50M
Gross Profit$ 5.01M$ 4.40M$ 9.68M$ 3.35M$ 6.23M
EBIT$ 19.00K$ -548.00K$ 4.56M$ -4.54M$ 1.06M
EBITDA$ 296.00K$ -346.00K$ 4.80M$ -4.30M$ 1.34M
Net Income Common Stockholders$ -811.00K$ -579.00K$ 4.56M$ 13.02M$ 912.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.66M$ 22.07M$ 21.57M$ 14.71M$ 16.30M
Total Assets$ 30.79M$ 31.53M$ 30.93M$ 23.87M$ 25.03M
Total Debt$ 5.02M$ 5.78M$ 6.16M$ 6.53M$ 6.52M
Net Debt$ -11.63M$ -16.29M$ -15.41M$ -8.18M$ -9.78M
Total Liabilities$ 15.30M$ 14.63M$ 14.21M$ 12.69M$ 11.95M
Stockholders Equity$ 15.49M$ 16.89M$ 16.73M$ 11.24M$ 13.08M
Cash Flow-
Free Cash Flow$ -4.36M$ 873.00K$ 7.10M$ -1.55M$ 2.83M
Operating Cash Flow$ -2.47M$ 873.00K$ 7.10M$ -1.55M$ 2.84M
Investing Cash Flow$ -1.88M---$ -12.00K
Financing Cash Flow$ -378.00K$ -368.00K$ -246.00K$ -49.00K$ 99.00K
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

Eton Pharmaceuticals Debt to Assets

Eton Pharmaceuticals Cash Flow

Eton Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis